Kalos Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,250
Closed -$204K 246
2020
Q2
$204K Sell
12,250
-250
-2% -$4.16K 0.09% 189
2020
Q1
$180K Buy
12,500
+1,750
+16% +$25.2K 0.08% 178
2019
Q4
$369K Hold
10,750
0.13% 144
2019
Q3
$238K Buy
+10,750
New +$238K 0.09% 165